Pharma & Healthcare
Global GLP-1 Receptor Agonist Drugs Market Research Report 2026
- Mar 17, 26
- ID: 738330
- Pages: 117
- Figures: 113
- Views: 10
This report delivers a comprehensive overview of the global GLP-1 Receptor Agonist Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GLP-1 Receptor Agonist Drugs. The GLP-1 Receptor Agonist Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GLP-1 Receptor Agonist Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GLP-1 Receptor Agonist Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
GSK
Hanson
Shanghai Renhui Biopharmaceutical
Huadong Medicine
Sino Biopharm
Segment by Type
Short-acting Preparations
Long-acting Preparations
Ultra-long-acting Preparations
by Application
Type 2 Diabetes
Obesity
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for GLP-1 Receptor Agonist Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines GLP-1 Receptor Agonist Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global GLP-1 Receptor Agonist Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GLP-1 Receptor Agonist Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
GSK
Hanson
Shanghai Renhui Biopharmaceutical
Huadong Medicine
Sino Biopharm
Segment by Type
Short-acting Preparations
Long-acting Preparations
Ultra-long-acting Preparations
by Application
Type 2 Diabetes
Obesity
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for GLP-1 Receptor Agonist Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines GLP-1 Receptor Agonist Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 GLP-1 Receptor Agonist Drugs Market Overview
1.1 Product Definition
1.2 GLP-1 Receptor Agonist Drugs by Type
1.2.1 Global GLP-1 Receptor Agonist Drugs Market Value by Type: 2025 vs 2032
1.2.2 Short-acting Preparations
1.2.3 Long-acting Preparations
1.2.4 Ultra-long-acting Preparations
1.3 GLP-1 Receptor Agonist Drugs by Application
1.3.1 Global GLP-1 Receptor Agonist Drugs Market Value by Application: 2025 vs 2032
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.4 Global GLP-1 Receptor Agonist Drugs Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Receptor Agonist Drugs Revenue 2021–2032
1.4.2 Global GLP-1 Receptor Agonist Drugs Sales 2021–2032
1.4.3 Global GLP-1 Receptor Agonist Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GLP-1 Receptor Agonist Drugs Market Competition by Manufacturers
2.1 Global GLP-1 Receptor Agonist Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GLP-1 Receptor Agonist Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GLP-1 Receptor Agonist Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Product Types and Applications
2.7 Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Date of Entry into the Industry
2.8 Global GLP-1 Receptor Agonist Drugs Market Competitive Situation and Trends
2.8.1 Global GLP-1 Receptor Agonist Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GLP-1 Receptor Agonist Drugs Players Market Share by Revenue
2.8.3 Global GLP-1 Receptor Agonist Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Receptor Agonist Drugs Market Scenario by Region
3.1 Global GLP-1 Receptor Agonist Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GLP-1 Receptor Agonist Drugs Sales by Region: 2021–2032
3.2.1 Global GLP-1 Receptor Agonist Drugs Sales by Region: 2021–2026
3.2.2 Global GLP-1 Receptor Agonist Drugs Sales by Region: 2027–2032
3.3 Global GLP-1 Receptor Agonist Drugs Revenue by Region: 2021–2032
3.3.1 Global GLP-1 Receptor Agonist Drugs Revenue by Region: 2021–2026
3.3.2 Global GLP-1 Receptor Agonist Drugs Revenue by Region: 2027–2032
3.4 North America GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.4.1 North America GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.4.3 North America GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.5.1 Europe GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.5.3 Europe GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Receptor Agonist Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Receptor Agonist Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GLP-1 Receptor Agonist Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.7.3 Latin America GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Receptor Agonist Drugs Sales by Type (2021–2032)
4.1.1 Global GLP-1 Receptor Agonist Drugs Sales by Type (2021–2026)
4.1.2 Global GLP-1 Receptor Agonist Drugs Sales by Type (2027–2032)
4.1.3 Global GLP-1 Receptor Agonist Drugs Sales Market Share by Type (2021–2032)
4.2 Global GLP-1 Receptor Agonist Drugs Revenue by Type (2021–2032)
4.2.1 Global GLP-1 Receptor Agonist Drugs Revenue by Type (2021–2026)
4.2.2 Global GLP-1 Receptor Agonist Drugs Revenue by Type (2027–2032)
4.2.3 Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Type (2021–2032)
4.3 Global GLP-1 Receptor Agonist Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global GLP-1 Receptor Agonist Drugs Sales by Application (2021–2032)
5.1.1 Global GLP-1 Receptor Agonist Drugs Sales by Application (2021–2026)
5.1.2 Global GLP-1 Receptor Agonist Drugs Sales by Application (2027–2032)
5.1.3 Global GLP-1 Receptor Agonist Drugs Sales Market Share by Application (2021–2032)
5.2 Global GLP-1 Receptor Agonist Drugs Revenue by Application (2021–2032)
5.2.1 Global GLP-1 Receptor Agonist Drugs Revenue by Application (2021–2026)
5.2.2 Global GLP-1 Receptor Agonist Drugs Revenue by Application (2027–2032)
5.2.3 Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Application (2021–2032)
5.3 Global GLP-1 Receptor Agonist Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novo Nordisk GLP-1 Receptor Agonist Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly GLP-1 Receptor Agonist Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AstraZeneca GLP-1 Receptor Agonist Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi GLP-1 Receptor Agonist Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 GSK
6.5.1 GSK Company Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 GSK GLP-1 Receptor Agonist Drugs Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Hanson
6.6.1 Hanson Company Information
6.6.2 Hanson Description and Business Overview
6.6.3 Hanson GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hanson GLP-1 Receptor Agonist Drugs Product Portfolio
6.6.5 Hanson Recent Developments/Updates
6.7 Shanghai Renhui Biopharmaceutical
6.7.1 Shanghai Renhui Biopharmaceutical Company Information
6.7.2 Shanghai Renhui Biopharmaceutical Description and Business Overview
6.7.3 Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Product Portfolio
6.7.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates
6.8 Huadong Medicine
6.8.1 Huadong Medicine Company Information
6.8.2 Huadong Medicine Description and Business Overview
6.8.3 Huadong Medicine GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Huadong Medicine GLP-1 Receptor Agonist Drugs Product Portfolio
6.8.5 Huadong Medicine Recent Developments/Updates
6.9 Sino Biopharm
6.9.1 Sino Biopharm Company Information
6.9.2 Sino Biopharm Description and Business Overview
6.9.3 Sino Biopharm GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sino Biopharm GLP-1 Receptor Agonist Drugs Product Portfolio
6.9.5 Sino Biopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Receptor Agonist Drugs Industry Chain Analysis
7.2 GLP-1 Receptor Agonist Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Receptor Agonist Drugs Production Mode & Process Analysis
7.4 GLP-1 Receptor Agonist Drugs Sales and Marketing
7.4.1 GLP-1 Receptor Agonist Drugs Sales Channels
7.4.2 GLP-1 Receptor Agonist Drugs Distributors
7.5 GLP-1 Receptor Agonist Drugs Customer Analysis
8 GLP-1 Receptor Agonist Drugs Market Dynamics
8.1 GLP-1 Receptor Agonist Drugs Industry Trends
8.2 GLP-1 Receptor Agonist Drugs Market Drivers
8.3 GLP-1 Receptor Agonist Drugs Market Challenges
8.4 GLP-1 Receptor Agonist Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 GLP-1 Receptor Agonist Drugs by Type
1.2.1 Global GLP-1 Receptor Agonist Drugs Market Value by Type: 2025 vs 2032
1.2.2 Short-acting Preparations
1.2.3 Long-acting Preparations
1.2.4 Ultra-long-acting Preparations
1.3 GLP-1 Receptor Agonist Drugs by Application
1.3.1 Global GLP-1 Receptor Agonist Drugs Market Value by Application: 2025 vs 2032
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.4 Global GLP-1 Receptor Agonist Drugs Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Receptor Agonist Drugs Revenue 2021–2032
1.4.2 Global GLP-1 Receptor Agonist Drugs Sales 2021–2032
1.4.3 Global GLP-1 Receptor Agonist Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GLP-1 Receptor Agonist Drugs Market Competition by Manufacturers
2.1 Global GLP-1 Receptor Agonist Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GLP-1 Receptor Agonist Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GLP-1 Receptor Agonist Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Product Types and Applications
2.7 Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Date of Entry into the Industry
2.8 Global GLP-1 Receptor Agonist Drugs Market Competitive Situation and Trends
2.8.1 Global GLP-1 Receptor Agonist Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GLP-1 Receptor Agonist Drugs Players Market Share by Revenue
2.8.3 Global GLP-1 Receptor Agonist Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Receptor Agonist Drugs Market Scenario by Region
3.1 Global GLP-1 Receptor Agonist Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GLP-1 Receptor Agonist Drugs Sales by Region: 2021–2032
3.2.1 Global GLP-1 Receptor Agonist Drugs Sales by Region: 2021–2026
3.2.2 Global GLP-1 Receptor Agonist Drugs Sales by Region: 2027–2032
3.3 Global GLP-1 Receptor Agonist Drugs Revenue by Region: 2021–2032
3.3.1 Global GLP-1 Receptor Agonist Drugs Revenue by Region: 2021–2026
3.3.2 Global GLP-1 Receptor Agonist Drugs Revenue by Region: 2027–2032
3.4 North America GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.4.1 North America GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.4.3 North America GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.5.1 Europe GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.5.3 Europe GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Receptor Agonist Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Receptor Agonist Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GLP-1 Receptor Agonist Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.7.3 Latin America GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Receptor Agonist Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Receptor Agonist Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GLP-1 Receptor Agonist Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Receptor Agonist Drugs Sales by Type (2021–2032)
4.1.1 Global GLP-1 Receptor Agonist Drugs Sales by Type (2021–2026)
4.1.2 Global GLP-1 Receptor Agonist Drugs Sales by Type (2027–2032)
4.1.3 Global GLP-1 Receptor Agonist Drugs Sales Market Share by Type (2021–2032)
4.2 Global GLP-1 Receptor Agonist Drugs Revenue by Type (2021–2032)
4.2.1 Global GLP-1 Receptor Agonist Drugs Revenue by Type (2021–2026)
4.2.2 Global GLP-1 Receptor Agonist Drugs Revenue by Type (2027–2032)
4.2.3 Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Type (2021–2032)
4.3 Global GLP-1 Receptor Agonist Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global GLP-1 Receptor Agonist Drugs Sales by Application (2021–2032)
5.1.1 Global GLP-1 Receptor Agonist Drugs Sales by Application (2021–2026)
5.1.2 Global GLP-1 Receptor Agonist Drugs Sales by Application (2027–2032)
5.1.3 Global GLP-1 Receptor Agonist Drugs Sales Market Share by Application (2021–2032)
5.2 Global GLP-1 Receptor Agonist Drugs Revenue by Application (2021–2032)
5.2.1 Global GLP-1 Receptor Agonist Drugs Revenue by Application (2021–2026)
5.2.2 Global GLP-1 Receptor Agonist Drugs Revenue by Application (2027–2032)
5.2.3 Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Application (2021–2032)
5.3 Global GLP-1 Receptor Agonist Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novo Nordisk GLP-1 Receptor Agonist Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly GLP-1 Receptor Agonist Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AstraZeneca GLP-1 Receptor Agonist Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi GLP-1 Receptor Agonist Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 GSK
6.5.1 GSK Company Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 GSK GLP-1 Receptor Agonist Drugs Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Hanson
6.6.1 Hanson Company Information
6.6.2 Hanson Description and Business Overview
6.6.3 Hanson GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hanson GLP-1 Receptor Agonist Drugs Product Portfolio
6.6.5 Hanson Recent Developments/Updates
6.7 Shanghai Renhui Biopharmaceutical
6.7.1 Shanghai Renhui Biopharmaceutical Company Information
6.7.2 Shanghai Renhui Biopharmaceutical Description and Business Overview
6.7.3 Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Product Portfolio
6.7.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates
6.8 Huadong Medicine
6.8.1 Huadong Medicine Company Information
6.8.2 Huadong Medicine Description and Business Overview
6.8.3 Huadong Medicine GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Huadong Medicine GLP-1 Receptor Agonist Drugs Product Portfolio
6.8.5 Huadong Medicine Recent Developments/Updates
6.9 Sino Biopharm
6.9.1 Sino Biopharm Company Information
6.9.2 Sino Biopharm Description and Business Overview
6.9.3 Sino Biopharm GLP-1 Receptor Agonist Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sino Biopharm GLP-1 Receptor Agonist Drugs Product Portfolio
6.9.5 Sino Biopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Receptor Agonist Drugs Industry Chain Analysis
7.2 GLP-1 Receptor Agonist Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Receptor Agonist Drugs Production Mode & Process Analysis
7.4 GLP-1 Receptor Agonist Drugs Sales and Marketing
7.4.1 GLP-1 Receptor Agonist Drugs Sales Channels
7.4.2 GLP-1 Receptor Agonist Drugs Distributors
7.5 GLP-1 Receptor Agonist Drugs Customer Analysis
8 GLP-1 Receptor Agonist Drugs Market Dynamics
8.1 GLP-1 Receptor Agonist Drugs Industry Trends
8.2 GLP-1 Receptor Agonist Drugs Market Drivers
8.3 GLP-1 Receptor Agonist Drugs Market Challenges
8.4 GLP-1 Receptor Agonist Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global GLP-1 Receptor Agonist Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global GLP-1 Receptor Agonist Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global GLP-1 Receptor Agonist Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global GLP-1 Receptor Agonist Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global GLP-1 Receptor Agonist Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market GLP-1 Receptor Agonist Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of GLP-1 Receptor Agonist Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Receptor Agonist Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Receptor Agonist Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Receptor Agonist Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2021–2026
Table 18. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Region (2021–2026)
Table 19. Global GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2027–2032
Table 20. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Region (2027–2032)
Table 21. Global GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 27. North America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 28. North America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Type (2021–2026)
Table 53. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Type (2027–2032)
Table 54. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Application (2021–2026)
Table 63. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Application (2027–2032)
Table 64. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk GLP-1 Receptor Agonist Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly GLP-1 Receptor Agonist Drugs Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AstraZeneca GLP-1 Receptor Agonist Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanofi GLP-1 Receptor Agonist Drugs Product
Table 89. Sanofi Recent Developments/Updates
Table 90. GSK Company Information
Table 91. GSK Description and Business Overview
Table 92. GSK GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. GSK GLP-1 Receptor Agonist Drugs Product
Table 94. GSK Recent Developments/Updates
Table 95. Hanson Company Information
Table 96. Hanson Description and Business Overview
Table 97. Hanson GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hanson GLP-1 Receptor Agonist Drugs Product
Table 99. Hanson Recent Developments/Updates
Table 100. Shanghai Renhui Biopharmaceutical Company Information
Table 101. Shanghai Renhui Biopharmaceutical Description and Business Overview
Table 102. Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Product
Table 104. Shanghai Renhui Biopharmaceutical Recent Developments/Updates
Table 105. Huadong Medicine Company Information
Table 106. Huadong Medicine Description and Business Overview
Table 107. Huadong Medicine GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Huadong Medicine GLP-1 Receptor Agonist Drugs Product
Table 109. Huadong Medicine Recent Developments/Updates
Table 110. Sino Biopharm Company Information
Table 111. Sino Biopharm Description and Business Overview
Table 112. Sino Biopharm GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Sino Biopharm GLP-1 Receptor Agonist Drugs Product
Table 114. Sino Biopharm Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. GLP-1 Receptor Agonist Drugs Distributors List
Table 118. GLP-1 Receptor Agonist Drugs Customers List
Table 119. GLP-1 Receptor Agonist Drugs Market Trends
Table 120. GLP-1 Receptor Agonist Drugs Market Drivers
Table 121. GLP-1 Receptor Agonist Drugs Market Challenges
Table 122. GLP-1 Receptor Agonist Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Receptor Agonist Drugs
Figure 2. Global GLP-1 Receptor Agonist Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global GLP-1 Receptor Agonist Drugs Market Share by Type: 2025 & 2032
Figure 4. Short-acting Preparations Product Picture
Figure 5. Long-acting Preparations Product Picture
Figure 6. Ultra-long-acting Preparations Product Picture
Figure 7. Global GLP-1 Receptor Agonist Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global GLP-1 Receptor Agonist Drugs Market Share by Application: 2025 & 2032
Figure 9. Type 2 Diabetes
Figure 10. Obesity
Figure 11. Global GLP-1 Receptor Agonist Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global GLP-1 Receptor Agonist Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global GLP-1 Receptor Agonist Drugs Sales (K Units), 2021–2032
Figure 14. Global GLP-1 Receptor Agonist Drugs Average Price (US$/Unit), 2021–2032
Figure 15. GLP-1 Receptor Agonist Drugs Report Years Considered
Figure 16. GLP-1 Receptor Agonist Drugs Sales Share by Manufacturers in 2025
Figure 17. Global GLP-1 Receptor Agonist Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global GLP-1 Receptor Agonist Drugs Players: Market Share by Revenue in GLP-1 Receptor Agonist Drugs in 2025
Figure 19. GLP-1 Receptor Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global GLP-1 Receptor Agonist Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific GLP-1 Receptor Agonist Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of GLP-1 Receptor Agonist Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of GLP-1 Receptor Agonist Drugs by Type (2021–2032)
Figure 54. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of GLP-1 Receptor Agonist Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of GLP-1 Receptor Agonist Drugs by Application (2021–2032)
Figure 57. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. GLP-1 Receptor Agonist Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global GLP-1 Receptor Agonist Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global GLP-1 Receptor Agonist Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global GLP-1 Receptor Agonist Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global GLP-1 Receptor Agonist Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global GLP-1 Receptor Agonist Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market GLP-1 Receptor Agonist Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of GLP-1 Receptor Agonist Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of GLP-1 Receptor Agonist Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Receptor Agonist Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Receptor Agonist Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Receptor Agonist Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2021–2026
Table 18. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Region (2021–2026)
Table 19. Global GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2027–2032
Table 20. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Region (2027–2032)
Table 21. Global GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 27. North America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 28. North America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific GLP-1 Receptor Agonist Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa GLP-1 Receptor Agonist Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Type (2021–2026)
Table 53. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Type (2027–2032)
Table 54. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global GLP-1 Receptor Agonist Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Application (2021–2026)
Table 63. Global GLP-1 Receptor Agonist Drugs Sales Market Share by Application (2027–2032)
Table 64. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global GLP-1 Receptor Agonist Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global GLP-1 Receptor Agonist Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk GLP-1 Receptor Agonist Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly GLP-1 Receptor Agonist Drugs Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AstraZeneca GLP-1 Receptor Agonist Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanofi GLP-1 Receptor Agonist Drugs Product
Table 89. Sanofi Recent Developments/Updates
Table 90. GSK Company Information
Table 91. GSK Description and Business Overview
Table 92. GSK GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. GSK GLP-1 Receptor Agonist Drugs Product
Table 94. GSK Recent Developments/Updates
Table 95. Hanson Company Information
Table 96. Hanson Description and Business Overview
Table 97. Hanson GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hanson GLP-1 Receptor Agonist Drugs Product
Table 99. Hanson Recent Developments/Updates
Table 100. Shanghai Renhui Biopharmaceutical Company Information
Table 101. Shanghai Renhui Biopharmaceutical Description and Business Overview
Table 102. Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Shanghai Renhui Biopharmaceutical GLP-1 Receptor Agonist Drugs Product
Table 104. Shanghai Renhui Biopharmaceutical Recent Developments/Updates
Table 105. Huadong Medicine Company Information
Table 106. Huadong Medicine Description and Business Overview
Table 107. Huadong Medicine GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Huadong Medicine GLP-1 Receptor Agonist Drugs Product
Table 109. Huadong Medicine Recent Developments/Updates
Table 110. Sino Biopharm Company Information
Table 111. Sino Biopharm Description and Business Overview
Table 112. Sino Biopharm GLP-1 Receptor Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Sino Biopharm GLP-1 Receptor Agonist Drugs Product
Table 114. Sino Biopharm Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. GLP-1 Receptor Agonist Drugs Distributors List
Table 118. GLP-1 Receptor Agonist Drugs Customers List
Table 119. GLP-1 Receptor Agonist Drugs Market Trends
Table 120. GLP-1 Receptor Agonist Drugs Market Drivers
Table 121. GLP-1 Receptor Agonist Drugs Market Challenges
Table 122. GLP-1 Receptor Agonist Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Receptor Agonist Drugs
Figure 2. Global GLP-1 Receptor Agonist Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global GLP-1 Receptor Agonist Drugs Market Share by Type: 2025 & 2032
Figure 4. Short-acting Preparations Product Picture
Figure 5. Long-acting Preparations Product Picture
Figure 6. Ultra-long-acting Preparations Product Picture
Figure 7. Global GLP-1 Receptor Agonist Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global GLP-1 Receptor Agonist Drugs Market Share by Application: 2025 & 2032
Figure 9. Type 2 Diabetes
Figure 10. Obesity
Figure 11. Global GLP-1 Receptor Agonist Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global GLP-1 Receptor Agonist Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global GLP-1 Receptor Agonist Drugs Sales (K Units), 2021–2032
Figure 14. Global GLP-1 Receptor Agonist Drugs Average Price (US$/Unit), 2021–2032
Figure 15. GLP-1 Receptor Agonist Drugs Report Years Considered
Figure 16. GLP-1 Receptor Agonist Drugs Sales Share by Manufacturers in 2025
Figure 17. Global GLP-1 Receptor Agonist Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global GLP-1 Receptor Agonist Drugs Players: Market Share by Revenue in GLP-1 Receptor Agonist Drugs in 2025
Figure 19. GLP-1 Receptor Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global GLP-1 Receptor Agonist Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific GLP-1 Receptor Agonist Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific GLP-1 Receptor Agonist Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa GLP-1 Receptor Agonist Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa GLP-1 Receptor Agonist Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE GLP-1 Receptor Agonist Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of GLP-1 Receptor Agonist Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of GLP-1 Receptor Agonist Drugs by Type (2021–2032)
Figure 54. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of GLP-1 Receptor Agonist Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of GLP-1 Receptor Agonist Drugs by Application (2021–2032)
Figure 57. Global GLP-1 Receptor Agonist Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. GLP-1 Receptor Agonist Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232